Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tzouvelekis (Athens, Greece), T. Karampitsakos (Athens, Greece), G. Gomatou (Athens, Greece), V. Tzilas (Athens, Greece), E. Bouros (Athens, Greece), S. Chrysikos (Athens, Greece), E. Markozannes (Athens, Greece), L. Kolilekas (Athens, Greece), E. Manali (Athens, Greece), I. Tomos (Athens, Greece), I. Korbila (Athens, Greece), P. Tomos (Athens, Greece), K. Loverdos (Athens, Greece), A. Gaga (Athens, Greece), K. Antoniou (Heraklion, Greece), A. Trachalaki (Heraklion, Greece), Z. Daniil (Larissa, Greece), F. Bardaka (Larissa, Greece), K. Markopoulou (Thessaloniki, Greece), S. Papiris (Athens, Greece), R. Tringidou (Athens, Greece), D. Bouros (Athens, Greece). Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study. 2908

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Europe. Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021 Incidence and prevalence of Systemic Sclerosis-associated Interstitial Lung Disease in a multicenter prospective cohort study. Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Idiopathic Pulmonary Fibrosis based on disease behavior: Workshop summary of a Japanese multicenter study Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Treatment dilemmas in sarcoidosis - a retrospective cohort study Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021 Year: 2022 Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study Source: International Congress 2014 – Sarcoidosis Year: 2014 Real-life data on the safety and tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) patients: A single-centre retrospective study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Clinical profile and early follow-up of patients receiving pirfenidone in the PIONEER observational study Source: International Congress 2014 – ILDs 6 Year: 2014 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Prevalence of idiopathic pulmonary fibrosis in Japan and the US: a claims-based retrospective study Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Home oxygen saturation monitoring and quality of life in patients with idiopathic pulmonary fibrosis: A prospective multicenter trial Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Seasonality of hypercalcemia - A population-based study on patients with pulmonary sarcoidosis Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Comorbidities in sarcoidosis: a retrospective Italian study Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020